Acta Endoscopica

, 41:281 | Cite as

Surveillance de l’endobrachyœsophage et modalités thérapeutiques

Vidéo-Digest / Video-Digest
  • 48 Downloads

Monitoring of Barrett’s oesophagus and therapeutic options

Références

  1. 1.
    Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–1920.PubMedCrossRefGoogle Scholar
  2. 2.
    Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s oesophagus: the Prague C & M criteria. gastroenterology 2006;131:1392–1399.PubMedCrossRefGoogle Scholar
  3. 3.
    Boyer J, Laugier R, Chemali M, Arpurt JP, Boustière C, Canard JM, et al. French society of Digestive Endoscopy (sFED) guideline: monitoring of patients with Barrett’s oesophagus. Endoscopy 2007;39:840–842.PubMedCrossRefGoogle Scholar
  4. 4.
    Cooper BT, Chapman W, Neumann CS, Gearty JC. Continuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006;23:727–733.PubMedCrossRefGoogle Scholar
  5. 5.
    Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s oesophagus with dysplasia. N Engl J Med 2009;360:2277–2288.PubMedCrossRefGoogle Scholar
  6. 6.
    Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–578.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2011

Authors and Affiliations

  1. 1.Service d’hépatogastroentérologieCHU de la Cavale-BlancheBrest cedexFrance
  2. 2.LilleFrance

Personalised recommendations